nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0945	0.168	CbGbCtD
Nisoldipine—CYP1A2—Leflunomide—systemic scleroderma	0.0902	0.16	CbGbCtD
Nisoldipine—ABCB1—Lisinopril—systemic scleroderma	0.0827	0.147	CbGbCtD
Nisoldipine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0749	0.133	CbGbCtD
Nisoldipine—ABCB1—Captopril—systemic scleroderma	0.0619	0.11	CbGbCtD
Nisoldipine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0487	0.0864	CbGbCtD
Nisoldipine—ABCB1—Prednisone—systemic scleroderma	0.0389	0.0691	CbGbCtD
Nisoldipine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0292	0.0518	CbGbCtD
Nisoldipine—CYP3A4—Prednisone—systemic scleroderma	0.0233	0.0414	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—systemic scleroderma	0.0195	0.0346	CbGbCtD
Nisoldipine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000446	0.00102	CcSEcCtD
Nisoldipine—Tachycardia—Leflunomide—systemic scleroderma	0.000446	0.00102	CcSEcCtD
Nisoldipine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000444	0.00102	CcSEcCtD
Nisoldipine—Anaemia—Lisinopril—systemic scleroderma	0.000444	0.00102	CcSEcCtD
Nisoldipine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000441	0.00101	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00044	0.00101	CcSEcCtD
Nisoldipine—Angioedema—Lisinopril—systemic scleroderma	0.000439	0.00101	CcSEcCtD
Nisoldipine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000439	0.00101	CcSEcCtD
Nisoldipine—Body temperature increased—Captopril—systemic scleroderma	0.000438	0.001	CcSEcCtD
Nisoldipine—Oedema—Mycophenolic acid—systemic scleroderma	0.000436	0.000999	CcSEcCtD
Nisoldipine—Anorexia—Leflunomide—systemic scleroderma	0.000435	0.000998	CcSEcCtD
Nisoldipine—Dry skin—Prednisone—systemic scleroderma	0.000434	0.000996	CcSEcCtD
Nisoldipine—Nausea—Pentoxifylline—systemic scleroderma	0.000434	0.000995	CcSEcCtD
Nisoldipine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000434	0.000995	CcSEcCtD
Nisoldipine—Malaise—Lisinopril—systemic scleroderma	0.000433	0.000994	CcSEcCtD
Nisoldipine—Vertigo—Lisinopril—systemic scleroderma	0.000432	0.00099	CcSEcCtD
Nisoldipine—Diarrhoea—Mometasone—systemic scleroderma	0.000431	0.000989	CcSEcCtD
Nisoldipine—Hypokalaemia—Prednisone—systemic scleroderma	0.000431	0.000989	CcSEcCtD
Nisoldipine—Syncope—Lisinopril—systemic scleroderma	0.000431	0.000988	CcSEcCtD
Nisoldipine—Leukopenia—Lisinopril—systemic scleroderma	0.00043	0.000986	CcSEcCtD
Nisoldipine—Shock—Mycophenolic acid—systemic scleroderma	0.000428	0.000982	CcSEcCtD
Nisoldipine—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000427	0.00098	CcSEcCtD
Nisoldipine—Hypotension—Leflunomide—systemic scleroderma	0.000427	0.000978	CcSEcCtD
Nisoldipine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000425	0.000975	CcSEcCtD
Nisoldipine—Palpitations—Lisinopril—systemic scleroderma	0.000425	0.000974	CcSEcCtD
Nisoldipine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000422	0.000969	CcSEcCtD
Nisoldipine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000421	0.000965	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00042	0.000963	CcSEcCtD
Nisoldipine—Cough—Lisinopril—systemic scleroderma	0.000419	0.000962	CcSEcCtD
Nisoldipine—Muscular weakness—Prednisone—systemic scleroderma	0.000418	0.000959	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000416	0.000954	CcSEcCtD
Nisoldipine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000415	0.000952	CcSEcCtD
Nisoldipine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000415	0.000951	CcSEcCtD
Nisoldipine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000413	0.000948	CcSEcCtD
Nisoldipine—Insomnia—Leflunomide—systemic scleroderma	0.000413	0.000947	CcSEcCtD
Nisoldipine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000946	CcSEcCtD
Nisoldipine—Paraesthesia—Leflunomide—systemic scleroderma	0.00041	0.00094	CcSEcCtD
Nisoldipine—Myalgia—Lisinopril—systemic scleroderma	0.000409	0.000938	CcSEcCtD
Nisoldipine—Arthralgia—Lisinopril—systemic scleroderma	0.000409	0.000938	CcSEcCtD
Nisoldipine—Chest pain—Lisinopril—systemic scleroderma	0.000409	0.000938	CcSEcCtD
Nisoldipine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000409	0.000938	CcSEcCtD
Nisoldipine—Anxiety—Lisinopril—systemic scleroderma	0.000408	0.000935	CcSEcCtD
Nisoldipine—Dyspnoea—Leflunomide—systemic scleroderma	0.000407	0.000933	CcSEcCtD
Nisoldipine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000407	0.000933	CcSEcCtD
Nisoldipine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000928	CcSEcCtD
Nisoldipine—Discomfort—Lisinopril—systemic scleroderma	0.000404	0.000927	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000404	0.000927	CcSEcCtD
Nisoldipine—Dyspepsia—Leflunomide—systemic scleroderma	0.000402	0.000921	CcSEcCtD
Nisoldipine—Dry mouth—Lisinopril—systemic scleroderma	0.0004	0.000918	CcSEcCtD
Nisoldipine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000398	0.000913	CcSEcCtD
Nisoldipine—Rash—Mometasone—systemic scleroderma	0.000398	0.000912	CcSEcCtD
Nisoldipine—Dermatitis—Mometasone—systemic scleroderma	0.000397	0.000911	CcSEcCtD
Nisoldipine—Decreased appetite—Leflunomide—systemic scleroderma	0.000397	0.00091	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000397	0.00091	CcSEcCtD
Nisoldipine—Confusional state—Lisinopril—systemic scleroderma	0.000396	0.000907	CcSEcCtD
Nisoldipine—Headache—Mometasone—systemic scleroderma	0.000395	0.000906	CcSEcCtD
Nisoldipine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000905	CcSEcCtD
Nisoldipine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000394	0.000903	CcSEcCtD
Nisoldipine—Oedema—Lisinopril—systemic scleroderma	0.000392	0.000899	CcSEcCtD
Nisoldipine—Pruritus—Captopril—systemic scleroderma	0.000392	0.000899	CcSEcCtD
Nisoldipine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000391	0.000897	CcSEcCtD
Nisoldipine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000391	0.000896	CcSEcCtD
Nisoldipine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000389	0.000892	CcSEcCtD
Nisoldipine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000388	0.00089	CcSEcCtD
Nisoldipine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000387	0.000888	CcSEcCtD
Nisoldipine—Shock—Lisinopril—systemic scleroderma	0.000386	0.000885	CcSEcCtD
Nisoldipine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000882	CcSEcCtD
Nisoldipine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000383	0.000879	CcSEcCtD
Nisoldipine—Tachycardia—Lisinopril—systemic scleroderma	0.000383	0.000878	CcSEcCtD
Nisoldipine—Body temperature increased—Azathioprine—systemic scleroderma	0.000382	0.000876	CcSEcCtD
Nisoldipine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00038	0.000871	CcSEcCtD
Nisoldipine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000379	0.000869	CcSEcCtD
Nisoldipine—Diarrhoea—Captopril—systemic scleroderma	0.000379	0.000869	CcSEcCtD
Nisoldipine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000379	0.000868	CcSEcCtD
Nisoldipine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000868	CcSEcCtD
Nisoldipine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000866	CcSEcCtD
Nisoldipine—Erectile dysfunction—Prednisone—systemic scleroderma	0.000377	0.000865	CcSEcCtD
Nisoldipine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000377	0.000864	CcSEcCtD
Nisoldipine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000376	0.000863	CcSEcCtD
Nisoldipine—Nausea—Mometasone—systemic scleroderma	0.000375	0.000859	CcSEcCtD
Nisoldipine—Anorexia—Lisinopril—systemic scleroderma	0.000374	0.000857	CcSEcCtD
Nisoldipine—Weight increased—Prednisone—systemic scleroderma	0.000373	0.000855	CcSEcCtD
Nisoldipine—Ataxia—Methotrexate—systemic scleroderma	0.000372	0.000854	CcSEcCtD
Nisoldipine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000372	0.000853	CcSEcCtD
Nisoldipine—Weight decreased—Prednisone—systemic scleroderma	0.000371	0.00085	CcSEcCtD
Nisoldipine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00037	0.000849	CcSEcCtD
Nisoldipine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000843	CcSEcCtD
Nisoldipine—Hypotension—Lisinopril—systemic scleroderma	0.000367	0.00084	CcSEcCtD
Nisoldipine—Dizziness—Captopril—systemic scleroderma	0.000366	0.00084	CcSEcCtD
Nisoldipine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000366	0.000839	CcSEcCtD
Nisoldipine—Urticaria—Leflunomide—systemic scleroderma	0.000363	0.000832	CcSEcCtD
Nisoldipine—Body temperature increased—Leflunomide—systemic scleroderma	0.000361	0.000827	CcSEcCtD
Nisoldipine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00036	0.000826	CcSEcCtD
Nisoldipine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000359	0.000823	CcSEcCtD
Nisoldipine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000822	CcSEcCtD
Nisoldipine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000822	CcSEcCtD
Nisoldipine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000822	CcSEcCtD
Nisoldipine—Myocardial infarction—Prednisone—systemic scleroderma	0.000358	0.000821	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000357	0.000819	CcSEcCtD
Nisoldipine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000357	0.000819	CcSEcCtD
Nisoldipine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000356	0.000817	CcSEcCtD
Nisoldipine—Insomnia—Lisinopril—systemic scleroderma	0.000355	0.000813	CcSEcCtD
Nisoldipine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000812	CcSEcCtD
Nisoldipine—Paraesthesia—Lisinopril—systemic scleroderma	0.000352	0.000808	CcSEcCtD
Nisoldipine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000351	0.000804	CcSEcCtD
Nisoldipine—Dyspnoea—Lisinopril—systemic scleroderma	0.00035	0.000802	CcSEcCtD
Nisoldipine—Rash—Captopril—systemic scleroderma	0.000349	0.000801	CcSEcCtD
Nisoldipine—Dermatitis—Captopril—systemic scleroderma	0.000349	0.0008	CcSEcCtD
Nisoldipine—Somnolence—Lisinopril—systemic scleroderma	0.000349	0.0008	CcSEcCtD
Nisoldipine—Headache—Captopril—systemic scleroderma	0.000347	0.000796	CcSEcCtD
Nisoldipine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000795	CcSEcCtD
Nisoldipine—Dyspepsia—Lisinopril—systemic scleroderma	0.000345	0.000792	CcSEcCtD
Nisoldipine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000344	0.000789	CcSEcCtD
Nisoldipine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000788	CcSEcCtD
Nisoldipine—Asthma—Methotrexate—systemic scleroderma	0.000342	0.000785	CcSEcCtD
Nisoldipine—Decreased appetite—Lisinopril—systemic scleroderma	0.000341	0.000782	CcSEcCtD
Nisoldipine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000775	CcSEcCtD
Nisoldipine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000336	0.000771	CcSEcCtD
Nisoldipine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000335	0.000769	CcSEcCtD
Nisoldipine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000332	0.000762	CcSEcCtD
Nisoldipine—Diarrhoea—Azathioprine—systemic scleroderma	0.000331	0.000758	CcSEcCtD
Nisoldipine—Nausea—Captopril—systemic scleroderma	0.000329	0.000754	CcSEcCtD
Nisoldipine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000328	0.000751	CcSEcCtD
Nisoldipine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000323	0.000741	CcSEcCtD
Nisoldipine—Pruritus—Leflunomide—systemic scleroderma	0.000323	0.000741	CcSEcCtD
Nisoldipine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000321	0.000736	CcSEcCtD
Nisoldipine—Dysuria—Methotrexate—systemic scleroderma	0.00032	0.000734	CcSEcCtD
Nisoldipine—Dizziness—Azathioprine—systemic scleroderma	0.00032	0.000733	CcSEcCtD
Nisoldipine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000315	0.000723	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000718	CcSEcCtD
Nisoldipine—Diarrhoea—Leflunomide—systemic scleroderma	0.000312	0.000716	CcSEcCtD
Nisoldipine—Urticaria—Lisinopril—systemic scleroderma	0.000312	0.000715	CcSEcCtD
Nisoldipine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000713	CcSEcCtD
Nisoldipine—Body temperature increased—Lisinopril—systemic scleroderma	0.00031	0.000711	CcSEcCtD
Nisoldipine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000708	CcSEcCtD
Nisoldipine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000308	0.000706	CcSEcCtD
Nisoldipine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000703	CcSEcCtD
Nisoldipine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000701	CcSEcCtD
Nisoldipine—Rash—Azathioprine—systemic scleroderma	0.000305	0.000699	CcSEcCtD
Nisoldipine—Dermatitis—Azathioprine—systemic scleroderma	0.000305	0.000698	CcSEcCtD
Nisoldipine—Headache—Azathioprine—systemic scleroderma	0.000303	0.000694	CcSEcCtD
Nisoldipine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000694	CcSEcCtD
Nisoldipine—Dizziness—Leflunomide—systemic scleroderma	0.000302	0.000692	CcSEcCtD
Nisoldipine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000299	0.000685	CcSEcCtD
Nisoldipine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000298	0.000683	CcSEcCtD
Nisoldipine—Stomatitis—Methotrexate—systemic scleroderma	0.000298	0.000682	CcSEcCtD
Nisoldipine—Conjunctivitis—Methotrexate—systemic scleroderma	0.000297	0.00068	CcSEcCtD
Nisoldipine—Sweating—Methotrexate—systemic scleroderma	0.000293	0.000671	CcSEcCtD
Nisoldipine—Haematuria—Methotrexate—systemic scleroderma	0.000291	0.000667	CcSEcCtD
Nisoldipine—Alopecia—Prednisone—systemic scleroderma	0.00029	0.000664	CcSEcCtD
Nisoldipine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000289	0.000663	CcSEcCtD
Nisoldipine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000288	0.00066	CcSEcCtD
Nisoldipine—Epistaxis—Methotrexate—systemic scleroderma	0.000288	0.00066	CcSEcCtD
Nisoldipine—Rash—Leflunomide—systemic scleroderma	0.000288	0.00066	CcSEcCtD
Nisoldipine—Dermatitis—Leflunomide—systemic scleroderma	0.000288	0.000659	CcSEcCtD
Nisoldipine—Nausea—Azathioprine—systemic scleroderma	0.000287	0.000658	CcSEcCtD
Nisoldipine—Headache—Leflunomide—systemic scleroderma	0.000286	0.000656	CcSEcCtD
Nisoldipine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000649	CcSEcCtD
Nisoldipine—Pruritus—Lisinopril—systemic scleroderma	0.000278	0.000636	CcSEcCtD
Nisoldipine—Rash—Mycophenolic acid—systemic scleroderma	0.000275	0.00063	CcSEcCtD
Nisoldipine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000274	0.000629	CcSEcCtD
Nisoldipine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000626	CcSEcCtD
Nisoldipine—Headache—Mycophenolic acid—systemic scleroderma	0.000273	0.000626	CcSEcCtD
Nisoldipine—Pharyngitis—Methotrexate—systemic scleroderma	0.000272	0.000624	CcSEcCtD
Nisoldipine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000623	CcSEcCtD
Nisoldipine—Nausea—Leflunomide—systemic scleroderma	0.000271	0.000622	CcSEcCtD
Nisoldipine—Diarrhoea—Lisinopril—systemic scleroderma	0.000268	0.000615	CcSEcCtD
Nisoldipine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000265	0.000607	CcSEcCtD
Nisoldipine—Visual impairment—Methotrexate—systemic scleroderma	0.000264	0.000606	CcSEcCtD
Nisoldipine—Anaemia—Prednisone—systemic scleroderma	0.000264	0.000605	CcSEcCtD
Nisoldipine—Angioedema—Prednisone—systemic scleroderma	0.000261	0.000598	CcSEcCtD
Nisoldipine—Dizziness—Lisinopril—systemic scleroderma	0.000259	0.000595	CcSEcCtD
Nisoldipine—Nausea—Mycophenolic acid—systemic scleroderma	0.000259	0.000593	CcSEcCtD
Nisoldipine—Malaise—Prednisone—systemic scleroderma	0.000257	0.00059	CcSEcCtD
Nisoldipine—Vertigo—Prednisone—systemic scleroderma	0.000256	0.000588	CcSEcCtD
Nisoldipine—Syncope—Prednisone—systemic scleroderma	0.000256	0.000587	CcSEcCtD
Nisoldipine—Tinnitus—Methotrexate—systemic scleroderma	0.000256	0.000586	CcSEcCtD
Nisoldipine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000253	0.000581	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisone—systemic scleroderma	0.000251	0.000575	CcSEcCtD
Nisoldipine—Rash—Lisinopril—systemic scleroderma	0.000247	0.000567	CcSEcCtD
Nisoldipine—Dermatitis—Lisinopril—systemic scleroderma	0.000247	0.000567	CcSEcCtD
Nisoldipine—Chills—Methotrexate—systemic scleroderma	0.000246	0.000564	CcSEcCtD
Nisoldipine—Headache—Lisinopril—systemic scleroderma	0.000246	0.000563	CcSEcCtD
Nisoldipine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000558	CcSEcCtD
Nisoldipine—Arthralgia—Prednisone—systemic scleroderma	0.000243	0.000557	CcSEcCtD
Nisoldipine—Myalgia—Prednisone—systemic scleroderma	0.000243	0.000557	CcSEcCtD
Nisoldipine—Anxiety—Prednisone—systemic scleroderma	0.000242	0.000555	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—systemic scleroderma	0.000242	0.000555	CcSEcCtD
Nisoldipine—Discomfort—Prednisone—systemic scleroderma	0.00024	0.000551	CcSEcCtD
Nisoldipine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000539	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—systemic scleroderma	0.000234	0.000536	CcSEcCtD
Nisoldipine—Nausea—Lisinopril—systemic scleroderma	0.000233	0.000534	CcSEcCtD
Nisoldipine—Oedema—Prednisone—systemic scleroderma	0.000233	0.000534	CcSEcCtD
Nisoldipine—Shock—Prednisone—systemic scleroderma	0.000229	0.000526	CcSEcCtD
Nisoldipine—Tachycardia—Prednisone—systemic scleroderma	0.000227	0.000521	CcSEcCtD
Nisoldipine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000521	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000225	0.000516	CcSEcCtD
Nisoldipine—Anorexia—Prednisone—systemic scleroderma	0.000222	0.000509	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000221	0.000508	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—systemic scleroderma	0.00022	0.000506	CcSEcCtD
Nisoldipine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000497	CcSEcCtD
Nisoldipine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000496	CcSEcCtD
Nisoldipine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000494	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—systemic scleroderma	0.000215	0.000493	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—systemic scleroderma	0.000214	0.000491	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—systemic scleroderma	0.000214	0.00049	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000212	0.000487	CcSEcCtD
Nisoldipine—Insomnia—Prednisone—systemic scleroderma	0.000211	0.000483	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisone—systemic scleroderma	0.000209	0.00048	CcSEcCtD
Nisoldipine—Cough—Methotrexate—systemic scleroderma	0.000208	0.000477	CcSEcCtD
Nisoldipine—Dyspepsia—Prednisone—systemic scleroderma	0.000205	0.00047	CcSEcCtD
Nisoldipine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000204	0.000468	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—systemic scleroderma	0.000203	0.000466	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—systemic scleroderma	0.000203	0.000466	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—systemic scleroderma	0.000203	0.000466	CcSEcCtD
Nisoldipine—Decreased appetite—Prednisone—systemic scleroderma	0.000203	0.000464	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—systemic scleroderma	0.000201	0.00046	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—systemic scleroderma	0.000196	0.00045	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisone—systemic scleroderma	0.000192	0.00044	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000188	0.000432	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—systemic scleroderma	0.000186	0.000426	CcSEcCtD
Nisoldipine—Urticaria—Prednisone—systemic scleroderma	0.000185	0.000424	CcSEcCtD
Nisoldipine—Body temperature increased—Prednisone—systemic scleroderma	0.000184	0.000422	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—systemic scleroderma	0.000182	0.000417	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000177	0.000407	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—systemic scleroderma	0.000176	0.000404	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—systemic scleroderma	0.000175	0.000401	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—systemic scleroderma	0.000174	0.000398	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—systemic scleroderma	0.000173	0.000397	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisone—systemic scleroderma	0.000172	0.000394	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—systemic scleroderma	0.000171	0.000393	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—systemic scleroderma	0.000169	0.000388	CcSEcCtD
Nisoldipine—Pruritus—Prednisone—systemic scleroderma	0.000165	0.000378	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—systemic scleroderma	0.00016	0.000368	CcSEcCtD
Nisoldipine—Diarrhoea—Prednisone—systemic scleroderma	0.000159	0.000365	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—systemic scleroderma	0.000155	0.000355	CcSEcCtD
Nisoldipine—Dizziness—Prednisone—systemic scleroderma	0.000154	0.000353	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—systemic scleroderma	0.000154	0.000353	CcSEcCtD
Nisoldipine—Rash—Prednisone—systemic scleroderma	0.000147	0.000337	CcSEcCtD
Nisoldipine—Dermatitis—Prednisone—systemic scleroderma	0.000147	0.000336	CcSEcCtD
Nisoldipine—Headache—Prednisone—systemic scleroderma	0.000146	0.000335	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000143	0.000329	CcSEcCtD
Nisoldipine—Nausea—Prednisone—systemic scleroderma	0.000138	0.000317	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—systemic scleroderma	0.000138	0.000316	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—systemic scleroderma	0.000133	0.000305	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—systemic scleroderma	0.000129	0.000295	CcSEcCtD
Nisoldipine—Rash—Methotrexate—systemic scleroderma	0.000123	0.000281	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—systemic scleroderma	0.000123	0.000281	CcSEcCtD
Nisoldipine—Headache—Methotrexate—systemic scleroderma	0.000122	0.00028	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—systemic scleroderma	0.000116	0.000265	CcSEcCtD
